19 studies found for:    "Hematologic Agents"
Show Display Options
Rank Status Study
1 No longer available B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure
Condition: Type 1 Diabetes Mellitus
Interventions: Biological: Allogeneic Pancreatic Islet Cells;   Drug: Sirolimus;   Biological: Basiliximab;   Drug: Tacrolimus;   Drug: Antibacterial, Antifungal, and Antiviral Prophylaxis;   Drug: Trimethoprim/sulfamethoxazole;   Drug: Clotrimazole;   Drug: Valganciclovir;   Drug: Heparin;   Drug: Enoxaparin;   Drug: Pentoxifylline;   Drug: Aspirin
2 Terminated Prophylactic Cranial Irradiation (PCI) Versus no PCI in Non Small Cell Lung Cancer After a Response to Chemotherapy
Condition: Brain Metastases
Intervention: Radiation: Radiotherapy
3 Recruiting Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Practice (Sweden)
Condition: Acute Coronary Syndrome
Interventions: Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Standard of care drugs
4 Recruiting Prospective Observational Study Of Patients With Polycythemia Vera In US Clinical Practices (REVEAL)
Condition: Polycythemia Vera
Intervention:
5 Terminated Walking Effect of Long Term Ticagrelor in Subjects With PAD Who Have Undergone EVR
Condition: Peripheral Artery Disease (PAD)
Interventions: Drug: Ticagrelor;   Drug: Comparator
6 Unknown  RELAXED: Recurrent Embolism Lessened by Rivaroxaban for Acute Ischemic Stroke
Conditions: Stroke, Acute;   Atrial Fibrillation
Intervention: Other: This is an observational study
7 Recruiting Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Condition: Pre-diabetes
Interventions: Dietary Supplement: placebo;   Dietary Supplement: resveratrol
8 Completed Tranexamic Acid in Reverse Total Shoulder Arthroplasty
Conditions: Shoulder Joint Disease;   Complications; Arthroplasty;   Intraoperative Complications;   Blood Loss, Surgical
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
9 Recruiting Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Netherlands)
Conditions: Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions: Drug: Rivaroxoban (Xarelto, Bay59-7939);   Drug: Standard of care
10 Recruiting Study of Rivaroxaban Use and Potential Adverse Outcomes in Routine Clinical Pratice (Germany)
Conditions: Venous Thrombosis;   Pulmonary Embolism;   Atrial Fibrillation;   Acute Coronary Syndrome
Interventions: Drug: Rivaroxaban (Xarelto, Bay59-7939);   Drug: Standard of care
11 Completed Antiplatelet Effects of Ticagrelor Versus Clopidogrel in American Indian Patients
Condition: Coronary Artery Disease
Interventions: Drug: Ticagrelor;   Drug: Clopidogrel
12 Recruiting STOP-AUST: The Spot Sign and Tranexamic Acid On Preventing ICH Growth - AUStralasia Trial
Conditions: Intracerebral Haemorrhage;   Stroke
Interventions: Drug: Tranexamic Acid;   Drug: Placebo
13 Suspended Research Into the Effect of a Clot-dissolving Agent and Its Inhibitor
Condition: Acute Ischemic Stroke
Intervention:
14 Unknown  Need for Antepartum Thromboprophylaxis in Pregnant Women With One Prior Episode of Venous Thromboembolism (VTE)
Conditions: Venous Thromboembolism;   Deep Vein Thrombosis;   Pulmonary Embolism
Intervention:
15 Terminated The Intravascular Cooling in the Treatment of Stroke 2/3 Trial
Condition: Stroke, Acute
Interventions: Device: hypothermia;   Other: Group1: IV t-PA and normothermia
16 Completed Tailoring Of Platelet Inhibition to Avoid Stent Thrombosis
Conditions: Coronary Artery Disease;   Myocardial Infarction;   Stent Thrombosis;   Heart Diseases;   Acute Coronary Syndrome
Intervention: Drug: Clopidogrel
17 Completed
Has Results
Deep Vein Thrombosis Treatment With the Oral Direct Factor Xa Inhibitor Rivaroxaban in Patients Using a Strong CYP 3A4 Inducer
Conditions: Venous Thrombosis;   Deep Vein Thrombosis
Intervention: Drug: Rivaroxaban (Xarelto, BAY59-7939)
18 Active, not recruiting A Clinical Research on the Relation of Blood Drug Concentration and Calcium Folinate Rescued in High-dose MTX Therapy
Condition: Osteosarcoma
Intervention: Drug: Methotrexate,Calcium folinate
19 Withdrawn Penetration of Ertapenem Into Bone
Condition: Amputation
Intervention: Drug: ertapenem

Indicates status has not been verified in more than two years